Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-16.45	-14.74	-12.66
Graham Fair Price	0.00	156.43	156.43
PEG	inf	0.00	-0.73
Price/Book	13.93	3.07	2.69
Price/Cash Flow	13.93	52.52	46.10
Prices/Earnings	13.93	20.50	17.99
Price/Sales	13.93	3.50	3.07
Price/FCF	13.93	52.52	46.10
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.96	0.96
Operating Margin	0.00	0.32	0.32
ROA	0.00	< 0.005	< 0.005
ROE	0.04	0.04	0.00
ROIC	0.14	0.13	-7.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.24	-0.12	97.34
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	2.65	0.00	inf
EPS QOQ	-0.25	0.00	inf
FCF QOQ	-0.28	0.00	inf
Revenue QOQ	0.40	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.33	0.38	14.69
Quick Ratio	5.46	200.49	3569.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	170.55	170.55	0.00
Cash	47.38	687.71	1351.35
Capex	-0.83	-0.83	0.00
Free Cash Flow	9.95	9.95	0.00
Revenue	149.48	149.48	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	5.46	200.49	3569.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.97	-1.43	-46.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating